Integrity of mTORC2 is dependent on the rictor Gly-934 site

Oncogene

Volumn 31, Issue 16, 2012, Pages 2115-2120

  Aimbetov, R ^a,b   Chen, C H ^a,c   Bulgakova, O ^a,d   Abetov, D ^a,b   Bissenbaev, A K ^b   Bersimbaev, R I ^d   Sarbassov, D D ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AL FARABI KAZAKH NATIONAL UNIVERSITY   (Kazakhstan)

^c UNIVERSITY OF TEXAS   (United States)

^d LN Gumilyov Eurasian National University ^*  (Kazakhstan)

Author keywords

Akt; cell signaling; complex assembly; kinase; mTORC2

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN; PROTOR 1ALPHA PROTEIN; RICTOR PROTEIN; SERINE; SIN1 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CAENORHABDITIS ELEGANS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARRIER PROTEINS; GLYCINE; HUMANS; POINT MUTATION; TRANSCRIPTION FACTORS;

CAENORHABDITIS ELEGANS; MAMMALIA;

EID: 84859903360     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.404     Document Type: Article

References (27)

1. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB et al. (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269. (Pubitemid 27176852)
2. Bayascas JR. (2008). Dissecting the role of the 3-phosphoinositide- dependent protein kinase-1 (PDK1) signalling pathways. Cell Cycle 7: 2978-2982.
3. Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, Stokoe D et al. (1998). Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17: 313-325. (Pubitemid 28383008)
4. Bozulic L, Surucu B, Hynx D, Hemmings BA. (2008). PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 30: 203-213. (Pubitemid 351626686)
5. Cantley LC. (2002). The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
6. Chen C-H, Sarbassov DD. (2011). The mTOR kinase activity determines functional activity and integrity of mTORC2. J Biol Chem (resubmitted).
7. Chen CH, Shaikenov T, Peterson TR, Aimbetov R, Bissenbaev AK, Lee SW et al. (2011). ER stress inhibits mTORC2 and Akt signaling through GSK-3beta-mediated phosphorylation of rictor. Sci Signal 4: ra10.
8. Citri A, Yarden Y. (2006). EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505-516. (Pubitemid 44036456)
9. Cordes MH, Davidson AR, Sauer RT. (1996). Sequence space, folding and protein design. Curr Opin Struct Biol 6: 3-10. (Pubitemid 26073938)
10. Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA et al. (2006). mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 16: 1865-1870. (Pubitemid 44354144)
11. Gross JM, Yee D. (2003). The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: biology and therapeutic relevance. Cancer Metastasis Rev 22: 327-336. (Pubitemid 36791890)
12. Guertin DA, Sabatini DM. (2005). An expanding role for mTOR in cancer. Trends Mol Med 11: 353-361. (Pubitemid 41080576)
13. Guertin DA, Sabatini DM. (2007). Defining the role of mTOR in cancer. Cancer Cell 12: 9-22. (Pubitemid 47001784)
14. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY et al. (2006). SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127: 125-137. (Pubitemid 44466632)
15. Jones KT, Greer ER, Pearce D, Ashrafi K. (2009). Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol 7: e60.
16. Pearce LR, Huang X, Boudeau J, Pawlowski R, Wullschleger S, Deak M et al. (2007). Identification of Protor as a novel rictor-binding component of mTOR complex-2. Biochem J 405: 513-522. (Pubitemid 47172049)
17. Pearce LR, Komander D, Alessi DR. (2010). The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11: 9-22.
18. Pearce LR, Sommer EM, Sakamoto K, Wullschleger S, Alessi DR. (2011). Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. Biochem J 436: 169-179.
19. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H et al. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296-1302. (Pubitemid 38991819)
20. Sarbassov DD, Ali SM, Sabatini DM. (2005a). Growing roles for the mTOR pathway. Curr Opin Cell Biol 17: 596-603. (Pubitemid 41540408)
21. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. (2005b). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101. (Pubitemid 40262113)
22. Schlessinger J, Lemmon MA. (2003). SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003: RE12.
23. Shaw RJ, Cantley LC. (2006). Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441: 424-430. (Pubitemid 44050136)
24. Soukas AA, Kane EA, Carr CE, Melo JA, Ruvkun G. (2009). Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev 23: 496-511.
25. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB et al. (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279: 710-714. (Pubitemid 28144551)
26. Woo SY, Kim DH, Jun CB, Kim YM, Haar EV, Lee SI et al. (2007). PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. J Biol Chem 282: 25604-25612. (Pubitemid 47372842)
27. Zhang X, Yee D. (2000). Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. Breast Cancer Res 2: 170-175. (Pubitemid 32223581)